| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.007 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |